John M. Hatcher
Harvard University(US)International Waldenstrom's Macroglobulinemia Foundation(US)Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Chronic Lymphocytic Leukemia Research, Ubiquitin and proteasome pathways, Lymphoma Diagnosis and Treatment, Peptidase Inhibition and Analysis
Most-Cited Works
- → Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development(2020)350 cited
- → Recent Advances in Selective and Irreversible Covalent Ligand Development and Validation(2019)174 cited
- → Brain Penetrant LRRK2 Inhibitor(2012)131 cited
- → SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic Isoform(2018)127 cited
- → Crystal structure of human IRAK1(2017)84 cited
- → Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8(2018)83 cited
- → Copper(I)-Catalyzed Addition of Grignard Reagents to in Situ-Derived N-Sulfonyl Azoalkenes: An Umpolung Alkylation Procedure Applicable to the Formation of Up to Three Contiguous Quaternary Centers